Published in BMC Public Health on December 03, 2016
Collective dynamics of 'small-world' networks. Nature (1998) 98.45
Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med (2011) 69.36
Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet (2010) 16.90
The architecture of complex weighted networks. Proc Natl Acad Sci U S A (2004) 11.53
Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet (2008) 11.44
Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infect Dis (2009) 6.96
Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet (2011) 6.21
Measures of concurrency in networks and the spread of infectious disease. Math Biosci (1996) 3.96
Maximising the effect of combination HIV prevention through prioritisation of the people and places in greatest need: a modelling study. Lancet (2014) 3.88
The influence of concurrent partnerships on the dynamics of HIV/AIDS. Math Biosci (1992) 3.64
Likelihood-based inference for stochastic models of sexual network formation. Theor Popul Biol (2004) 3.06
Epidemiology of HIV infection in the Middle East and North Africa. AIDS (2010) 2.86
The transmission dynamics of human immunodeficiency virus (HIV). Philos Trans R Soc Lond B Biol Sci (1988) 2.35
A preliminary study of the transmission dynamics of the human immunodeficiency virus (HIV), the causative agent of AIDS. IMA J Math Appl Med Biol (1986) 2.18
Degree distributions in sexual networks: a framework for evaluating evidence. Sex Transm Dis (2008) 2.15
No HIV stage is dominant in driving the HIV epidemic in sub-Saharan Africa. AIDS (2008) 2.04
Risks of acquiring and transmitting sexually transmitted diseases in sexual partner networks. Sex Transm Dis (2000) 2.00
HIV, hepatitis C, and hepatitis B infections and associated risk behavior in injection drug users, Kabul, Afghanistan. Emerg Infect Dis (2007) 1.96
Sexual networks and HIV. AIDS (1997) 1.92
Risk of HIV-1 transmission for parenteral exposure and blood transfusion: a systematic review and meta-analysis. AIDS (2006) 1.70
HIV treatment as prevention: models, data, and questions--towards evidence-based decision-making. PLoS Med (2012) 1.62
Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis. Lancet Infect Dis (2016) 1.47
Characterising the progress in HIV/AIDS research in the Middle East and North Africa. Sex Transm Infect (2013) 1.42
HIV among people who inject drugs in the Middle East and North Africa: systematic review and data synthesis. PLoS Med (2014) 1.37
Can hepatitis C virus prevalence be used as a measure of injection-related human immunodeficiency virus risk in populations of injecting drug users? An ecological analysis. Addiction (2009) 1.30
HIV prevalence and related risk behaviours among female sex workers in Iran: results of the national biobehavioural survey, 2010. Sex Transm Infect (2013) 1.29
Investigating Voluntary Medical Male Circumcision Program Efficiency Gains through Subpopulation Prioritization: Insights from Application to Zambia. PLoS One (2015) 1.20
The risk of HIV transmission within HIV-1 sero-discordant couples appears to vary across sub-Saharan Africa. Epidemics (2013) 1.14
A Reevaluation of the Voluntary Medical Male Circumcision Scale-Up Plan in Zimbabwe. PLoS One (2015) 1.12
Estimating the cost-effectiveness of needle-syringe programs in Australia. AIDS (2012) 1.11
Prevalence of HIV, hepatitis B and hepatitis C and associated risk behaviours amongst injecting drug users in three Afghan cities. Int J Drug Policy (2010) 1.06
The impact of needle and syringe programs on HIV and HCV transmissions in injecting drug users in Australia: a model-based analysis. J Acquir Immune Defic Syndr (2009) 1.04
Understanding the trends in HIV and hepatitis C prevalence amongst injecting drug users in different settings--implications for intervention impact. Drug Alcohol Depend (2011) 0.96
Dynamics of non-cohabiting sex partnering in sub-Saharan Africa: a modelling study with implications for HIV transmission. Sex Transm Infect (2015) 0.92
Occupational transmission of hepatitis C in healthcare workers and factors associated with seroconversion: UK surveillance data. J Viral Hepat (2011) 0.91
Modelling the transmission of HIV and HCV among injecting drug users in Rawalpindi, a low HCV prevalence setting in Pakistan. Sex Transm Infect (2009) 0.86
Prevalence and correlates of HIV, syphilis, and hepatitis B and C infection and harm reduction program use among male injecting drug users in Kabul, Afghanistan: A cross-sectional assessment. Harm Reduct J (2011) 0.85
Determinants of persistent spread of HIV in HCV-infected populations of injecting drug users. Epidemics (2012) 0.84
Transmission of hepatitis C virus by occupational percutaneous injuries in South Korea. J Formos Med Assoc (2012) 0.83
Using hepatitis C prevalence to estimate HIV epidemic potential among people who inject drugs in the Middle East and North Africa. AIDS (2015) 0.82
Eligibility of persons who inject drugs for treatment of hepatitis C virus infection. World J Gastroenterol (2014) 0.82
Could there have been substantial declines in sexual risk behavior across sub-Saharan Africa in the mid-1990s? Epidemics (2014) 0.82
[Occupational medicine significance of hepatitis C in health care employees]. Gesundheitswesen (1997) 0.80
Hepatitis C virus and human immunodeficiency virus transmission routes: Differences and similarities. World J Hepatol (2013) 0.79
HIV, HCV, HBV, HSV, and syphilis prevalence among female sex workers in Tehran, Iran, by using respondent-driven sampling. AIDS Care (2015) 0.79